MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Debt to Asset Ratio
64.74%
Unit: Dollar
Assets Breakdown
Prepaid expenses and other curre...
Cash
Property, plant and equipment, n...
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable and accrued lia...
Common stock, 0.0001 par value 3...
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Balance Sheets
2026-04-30
Cash
710,689
Prepaid expenses and other current assets
1,053,808
Total current assets
1,764,497
Property, plant and equipment, net
314,866
Total assets
2,079,363
Accounts payable and accrued liabilities
1,346,152
Total liabilities, all current
1,346,152
Common stock, 0.0001 par value 300,000,000 shares authorized 4,256,039 and 778,733 issued and outstanding as of april 30, 2026 and 2025, respectively
425
Additional paid-in capital
68,040,429
Accumulated deficit
-67,307,643
Total stockholders equity
733,211
Total liabilities and stockholders equity
2,079,363
Page 1
Unit: Dollar.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$1,053,808
Cash
$710,689
Total current assets
$1,764,497
Property, plant and
equipment, net
$314,866
Total assets
$2,079,363
Total liabilities and
stockholders equity
$2,079,363
Total liabilities,
all current
$1,346,152
Total stockholders
equity
$733,211
Accumulated deficit
-$67,307,643
Accounts payable and
accrued liabilities
$1,346,152
Additional paid-in capital
$68,040,429
Common stock, 0.0001
par value...
$425
Buy us a coffee
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)